Alpine Immune Sciences researches, discovers, develops and commercializes protein-based immunotherapies for the treatment of cancer.
Business Model:
Revenue: $31.8M
Employees: 51-200
Address: 188 East Blaine Street
City: Seattle
State: WA
Zip: 98102
Country: US
Alpine Immune Sciences researches, discovers, develops and commercializes protein-based immunotherapies for the treatment of cancer.
Contact Phone:
+12067884545
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
6/19/2015
Ticker Symbol:
ALPN
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 1/2015 | Seed Round | $1.3M | 9/2021 | Private Placement | 8 | $91M |
Avidity Partners BVF Partners Decheng Capital Frazier Healthcare Partners Logos Capital Omega Funds OrbiMed TCG Crossover Avidity Partners BVF Partners Decheng Capital Frazier Healthcare Partners Logos Capital Omega Funds OrbiMed TCG Crossover |
1/2019 | Post-IPO Equity | 5 | $25M |
Decheng Capital Alpine BioVentures Biotechnology Value Fund Frazier Healthcare Partners OrbiMed Decheng Capital |
1/2019 | Private Placement | $25.3M | 7/2017 | IPO | $17M | 6/2016 | Equity | $10.3M | 7/2020 | Post-IPO Equity | 4 | $60M |
Avidity Partners Omega Funds Samsara BioCapital EcoR1 Capital Avidity Partners Omega Funds |
9/2022 | Post-IPO Equity | $100M | 6/2016 | Series A | 3 | $48M |
OrbiMed Alpine BioVentures Frazier Healthcare Partners OrbiMed |
---|
Announced Date | Name | Price |
---|---|---|
7/2017 | Nivalis Therapeutics |
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|